Brief: Meilleure Health International Industry Says Yunnan Hansu To Buy 35 Pct Stake In ACGT DNA Technologies
24/04/2019 10:41
April 24 (Reuters) - Meilleure Health International Industry
Group Ltd 2327.HK :
* ON APRIL 20, YUNNAN HANSU & HEMP INVESTMENT GROUP ENTERED
INVESTMENT DEAL WITH ACGT DNA TECHNOLOGIES CORP
* YUNNAN HANSU TO ACQUIRE 35% STAKE IN ACGT AND BECOME
SINGLE
LARGEST SHAREHOLDER OF ACGT
Source text for Eikon: urn:newsml:reuters.com:*:nHKSKLjgH
Further company coverage: 2327.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Meilleure Health International Industry
See all newsBrief: Meilleure Health International Industry To Buy Tech-Medi Development For HK$35.2 Mln
Hong Kong's Meilleure Health H1 revenue surges on property sales, but margins hit
Brief: Meilleure Health International Industry Expects HY Profit Attributable Of At Least HK$27 MLN
Brief: Meilleure Health International Industry To Buy Jiangsu Yide For RMB124.8 Million
Brief: Meilleure Health International Industry Expects Profit Of Hk$14-16 Million For H1 2025